Swiss pharmaceutical group Roche said Tuesday it would buy British pharmaceutical company Piramed for $160 (101 million euros), a move it said would boost its oncology and inflammatory disease activities.
In addition, Roche will pay $15 million when Piramed's oncology programme starts phase II clinical trials.
Completion of the deal is expected during the second quarter of 2008, said Roche.
Source
No comments:
Post a Comment